Rare facial pain condition that affected Salman Khan also solved for 46-year-old patient, according to Apollo doctor’s diagnosis
A 46-year-old man's persistent facial pain led to the discovery of a rare condition, trigeminal neuralgia, which was also famously battled by Bollywood superstar Salman Khan. The patient experienced severe, episodic pain on the right side of his face, specifically...
Delhi High Court bars Alchem International from utilizing the ‘ALCHEM’ trademark for pharmaceutical retail products.
Alkem Laboratories, one of India's largest pharmaceutical companies, has been embroiled in a trademark dispute with Alchem International, a manufacturer of plant-derived active ingredients and Ayurvedic extracts. The controversy centers around the use of the marks...
Delhi High Court grants interim relief to Sun Pharma in trademark dispute, restraining Alenvision from selling its NEXADOM medication amidst allegations of infringing on Sun Pharma’s NAXDOM trademark.
The Delhi High Court has granted interim relief to Sun Pharma in a trademark dispute over the name "NAXDOM". The court has barred Alenvision from manufacturing and selling a drug called "NEXADOM", which Sun Pharma claims is deceptively similar to their trademarked...
Indian authorities conduct searches at seven locations in Chennai tied to Sresan Pharma amidst investigations into deaths associated with Coldrif cough syrup.
The Enforcement Directorate (ED) has launched searches at seven locations in Chennai in connection with the Coldrif cough syrup case, which has resulted in the deaths of at least 22 children, primarily under the age of five. The searches are being conducted under the...
Dr Reddy’s and Zydus Lifesciences are recalling certain medications in the US due to concerns over their quality.
Dr. Reddy's and Zydus Lifesciences, two major Indian pharmaceutical companies, have initiated recalls of certain medicines in the US due to quality issues. The recalls were voluntarily undertaken by the companies by the US Food and Drug Administration (US FDA). Dr....
Biocon’s recently established US facility has successfully overcome a crucial regulatory obstacle imposed by the FDA.
Biocon Ltd. has successfully completed a critical Good Manufacturing Practices (GMP) inspection by the US Food and Drug Administration (FDA) at its first manufacturing facility in the US, located in Cranbury, New Jersey. The inspection, which is mandatory for...
Lupin receives one observation from the USFDA for its Somerset facility
Lupin, a pharmaceutical company, has received one observation from the US Food and Drug Administration (USFDA) for its facility located in Somerset, New Jersey. The USFDA observation is a result of an inspection conducted by the regulatory agency, which identified a...
Dr Reddy’s and Zydus have initiated recalls of certain products in the US market due to concerns regarding their quality.
Dr. Reddy's Laboratories and Zydus Lifesciences, two major pharmaceutical companies, are recalling certain products in the US due to manufacturing issues. According to the US Food and Drug Administration (USFDA), Dr. Reddy's Laboratories is recalling 571 vials of...
Delhi High Court grants interim relief to Sun Pharma in trademark dispute, restraining Alenvision from selling its NEXADOM medication amidst allegations of infringing on Sun Pharma’s NAXDOM trademark.
The Delhi High Court has granted interim relief to Sun Pharma in a trademark dispute over the name "NAXDOM". The court has barred Alenvision from manufacturing and selling a drug called "NEXADOM", which Sun Pharma claims is deceptively similar to their trademarked...
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association
Zydus Lifesciences' Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
Five pharmaceutical companies, including Sun Pharma and Zydus, have issued recalls for their products in the US market.
Sun Pharma, Zydus, and three other pharmaceutical companies have issued recalls for their products in the US market. The recalls were initiated due to various reasons, including contamination, labeling issues, and deviations from manufacturing standards. Sun Pharma,...
Several Indian pharmaceutical companies, including Glenmark, Granules, and Zydus, have issued recalls for certain medications in the US market due to concerns over quality, as reported by the US Food and Drug Administration (USFDA).
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, as reported by the US Food and Drug Administration (USFDA). The recalls are related to manufacturing problems, impurities, and labeling errors. Glenmark...
Several pharmaceutical companies, including Zydus, Sun Pharma, and Glenmark, have issued recalls of their medications in the US due to concerns regarding quality standards.
Several Indian pharmaceutical companies are recalling medicines from the US market due to various issues, including manufacturing problems, impurities, and labeling errors, as reported by the US Food and Drug Administration (USFDA). The recalls affect a range of...
Generic pharmaceutical companies dodge significant damage, avoiding a medical emergency.
India's generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump's 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies. However, some...
From Humble Beginnings to International Dominion
Dilip Shanghvi, the founder of Sun Pharmaceutical Industries (Sun Pharma), is one of India's most prominent self-made billionaires. Born in 1955 in Amreli, Gujarat, Shanghvi grew up in Kolkata, where his father ran a small pharmacy shop. From a young age, Shanghvi...
Natco Pharma set to purchase major shareholding in South African company Adcock Ingram
India's Natco Pharma has announced a significant investment in South Africa's 135-year-old pharmaceutical giant, Adcock Ingram. The R 4.2-billion deal will see Adcock Ingram become a privately-held entity co-owned by Natco and Bidvest, with Bidvest remaining the...
Natco Pharma considers splitting off its agricultural division.
Natco Pharma, a generic drugmaker, is considering spinning off its agro business into a separate entity. The company's board of directors has given in-principle approval for the demerger, which is expected to unlock value in the core pharmaceuticals business and Drive...
Rajiv Nannapaneni, the CEO of Natco Pharma
Rajiv Nannapaneni, CEO of Natco Pharma, believes that the Indian pharma sector is not threatened by the recent US trade tariffs. He attributes this to the fact that the US consumes 92% of Indian generic drugs, making it reliant on Indian pharmaceuticals. Nannapaneni...
Indian generic companies intensify challenge to Novo Nordisk’s weight-loss medication patent
A patent battle is unfolding in India between Danish pharmaceutical company Novo Nordisk and Indian pharmaceutical companies, particularly Hyderabad-based Natco Pharma. The dispute centers around Novo Nordisk's blockbuster weight-loss drug, semaglutide, which is sold...
Natco Pharma files lawsuit against Novo Nordisk in Delhi courts regarding intellectual property dispute over Semaglutide.
Natco Pharma, an Indian pharmaceutical company, has filed a lawsuit against Novo Nordisk, a Danish multinational pharmaceutical company, in a Delhi court over intellectual property rights related to semaglutide. Semaglutide is a medication used to treat type 2...
Natco Pharma names TC Mallikarjun as its new Vice President.
Natco Pharma, a leading pharmaceutical company, has announced the appointment of TC Mallikarjun as Vice President - Quality Control (QC) at its Kothur Pharma Division. This appointment is a significant development for the company, as it continues to strengthen its...
Access to the Request Has Been Denied
It appears that you have encountered an error while trying to access the website www.tipranks.com. The error message indicates that your request was blocked by Link11 Web Application Security, which is a security system designed to protect websites from malicious...
US FDA issues single Form 483 observation to NATCO Pharma’s Hyderabad plant following audit.
NATCO Pharma, a leading pharmaceutical company based in Hyderabad, India, has received a positive outcome from a recent US Food and Drug Administration (US FDA) audit. The company's plant, located in Hyderabad, was inspected by the US FDA, and the audit resulted in...
Rare facial pain condition that affected Salman Khan also solved for 46-year-old patient, according to Apollo doctor’s diagnosis
A 46-year-old man's persistent facial pain led to the discovery of a rare condition, trigeminal neuralgia, which was also famously battled by Bollywood superstar Salman Khan. The patient experienced severe, episodic pain on the right side of his face, specifically...
Delhi High Court bars Alchem International from utilizing the ‘ALCHEM’ trademark for pharmaceutical retail products.
Alkem Laboratories, one of India's largest pharmaceutical companies, has been embroiled in a trademark dispute with Alchem International, a manufacturer of plant-derived active ingredients and Ayurvedic extracts. The controversy centers around the use of the marks...
Delhi High Court grants interim relief to Sun Pharma in trademark dispute, restraining Alenvision from selling its NEXADOM medication amidst allegations of infringing on Sun Pharma’s NAXDOM trademark.
The Delhi High Court has granted interim relief to Sun Pharma in a trademark dispute over the name "NAXDOM". The court has barred Alenvision from manufacturing and selling a drug called "NEXADOM", which Sun Pharma claims is deceptively similar to their trademarked...
Indian authorities conduct searches at seven locations in Chennai tied to Sresan Pharma amidst investigations into deaths associated with Coldrif cough syrup.
The Enforcement Directorate (ED) has launched searches at seven locations in Chennai in connection with the Coldrif cough syrup case, which has resulted in the deaths of at least 22 children, primarily under the age of five. The searches are being conducted under the...
Dr Reddy’s and Zydus Lifesciences are recalling certain medications in the US due to concerns over their quality.
Dr. Reddy's and Zydus Lifesciences, two major Indian pharmaceutical companies, have initiated recalls of certain medicines in the US due to quality issues. The recalls were voluntarily undertaken by the companies by the US Food and Drug Administration (US FDA). Dr....
Biocon’s recently established US facility has successfully overcome a crucial regulatory obstacle imposed by the FDA.
Biocon Ltd. has successfully completed a critical Good Manufacturing Practices (GMP) inspection by the US Food and Drug Administration (FDA) at its first manufacturing facility in the US, located in Cranbury, New Jersey. The inspection, which is mandatory for...
Lupin receives one observation from the USFDA for its Somerset facility
Lupin, a pharmaceutical company, has received one observation from the US Food and Drug Administration (USFDA) for its facility located in Somerset, New Jersey. The USFDA observation is a result of an inspection conducted by the regulatory agency, which identified a...
Dr Reddy’s and Zydus have initiated recalls of certain products in the US market due to concerns regarding their quality.
Dr. Reddy's Laboratories and Zydus Lifesciences, two major pharmaceutical companies, are recalling certain products in the US due to manufacturing issues. According to the US Food and Drug Administration (USFDA), Dr. Reddy's Laboratories is recalling 571 vials of...
How He Transformed Cipla into a Worldwide Pharmaceutical Powerhouse
Yusuf Hamied, the Chairman of Cipla, is a leader who has transformed the global pharmaceutical landscape by advocating for affordable medications and lifesaving therapies. Born on July 25, 1936, in Vilnius, Lithuania, Hamied moved to India with his family and later...
Shivam Puri, Managing Director and CEO of Cipla Health Ltd, to serve on the Grand Jury for IMA 2025, as reported by Exchange4Media.
The Indian Media Awards (IMA) 2025 Grand Jury consists of esteemed industry professionals, including Shivam Puri, Managing Director & CEO of Cipla Health Ltd. As reported by Exchange4Media, the IMA 2025 aims to recognize and celebrate excellence in the media industry....
Dr Sharvil Patel of Zydus Lifesciences assumes the role of President at the Indian Pharmaceutical Association
Zydus Lifesciences' Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
China’s reduction in import duties helps alleviate the impact of US tariffs on India’s pharmaceutical industry.
The Indian pharmaceutical industry is facing a complex global trade landscape, with contrasting developments in China and the US. China has reduced import duties on Indian pharma products by 30%, effectively enabling near-zero-cost access, providing a significant...
Generic pharmaceutical companies dodge significant damage, avoiding a medical emergency.
India's generic pharmaceutical companies are likely to continue business as usual despite US President Donald Trump's 100% levy on pharmaceuticals. The tariff is targeted at branded and patented medicines, which may not directly impact generic companies. However, some...
Cipla Group company InvaGen Pharmaceuticals partners with Bora Biologics for production of NYPOZI at their San Diego facility.
Bora Biologics has partnered with InvaGen Pharmaceuticals, a subsidiary of Cipla Group, to manufacture NYPOZI(TM) at its San Diego facility. This partnership marks a significant milestone in the production of NYPOZI(TM), a crucial medication for patients in need. Bora...
Umang Vohra set to step down, with Achin Gupta poised to succeed as new Global CEO.
In a significant development, Cipla, a leading pharmaceutical company, is undergoing a leadership shift. Umang Vohra, the current Managing Director and Global Chief Executive Officer (CEO), has decided to exit the company. Vohra's departure marks the end of an era at...
Umang Vohra, Managing Director of Cipla, is reportedly set to resign, with Chief Operating Officer Achin Gupta likely to take over his position.
Indian pharmaceutical company Cipla is reportedly preparing for a significant management change. Umang Vohra, the company's managing director and global CEO, is expected to step down by the end of the current fiscal year. Vohra, 54, has been in the role for nearly a...
Rare facial pain condition that affected Salman Khan also solved for 46-year-old patient, according to Apollo doctor’s diagnosis
A 46-year-old man's persistent facial pain led to the discovery of a rare condition, trigeminal neuralgia, which was also famously battled by Bollywood superstar Salman Khan. The patient experienced severe, episodic pain on the right side of his face, specifically...
ICICI Securities has identified Apollo Hospitals and Metropolis as top choices in the healthcare sector, ahead of the release of Q2 results.
ICICI Securities has released its top picks in the healthcare sector, with Apollo Hospitals and Metropolis being the favored choices. This comes ahead of the Q2 results, which are expected to be released soon. The brokerage firm has maintained a "buy" rating on Apollo...
Neuberg Diagnostics opens a wellness centre and laboratory for processing in Chennai, as reported by Medical Buyer.
Neuberg Diagnostics has launched a new Wellness Centre and Processing Lab in Abhiramapuram, Chennai. The facility was inaugurated by Dr. Sengottuvelu G, a senior consultant and interventional cardiologist at Apollo Hospitals, in the presence of Dr. GSK Velu, the...
Mahindra University collaborates with Apollo Healthcare Academy to introduce Bachelor’s Programs in Allied Health Sciences through a Memorandum of Understanding, as reported by Chennai Patrika, a source for Tamil Cinema News, Kollywood News, and India News.
Mahindra University, Hyderabad, and Apollo Healthcare Academy have signed a Memorandum of Understanding (MoU) to offer Bachelor's programs in Allied Health Sciences. The partnership aims to address the growing shortage of allied health professionals in India and...
Mahindra University partners with Apollo Healthcare Academy to launch collaborative programme through Memorandum of Understanding
Mahindra University, located in Hyderabad, has partnered with Apollo Healthcare Academy to offer Bachelor's programs in Allied Health Sciences. The collaboration aims to produce practice-ready graduates who meet the demands of the healthcare industry. The programs...
Artificial intelligence, genomics, and the future trajectory of cardiac innovation are poised to revolutionize India’s healthcare economy.
Cardiovascular disease is a significant health challenge in India, affecting people at a younger age and resulting in increased morbidity, premature deaths, and high healthcare expenditures. To address this, technology such as Artificial Intelligence (AI) and genomics...
Apollo Hospitals inks deal with Iraq to operate Internal Security Force Hospital, reports ETHealthworld
Apollo Hospitals has signed an agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. This partnership aims to provide advanced medical care to Iraq's security forces and their families, further...
Apollo Hospitals inks deal to run Iraq’s Internal Security Force Hospital
Apollo Hospitals has signed a strategic agreement with the Ministry of Interior, Republic of Iraq, to manage and operate the Internal Security Force Hospital. This partnership aims to provide advanced medical care to Iraq's security forces and their families, further...
Pfizer’s COVID-19 vaccine side effect documents, normally sealed for 75 years, were disclosed 63 years ahead of schedule, exposing over 85,000 pages detailing various adverse reactions.
The medical community worldwide is reeling from a recent US court decision that has forced the Food and Drug Administration (FDA) and Pfizer to release confidential documents related to COVID-19 vaccine side effects. Initially, these documents were set to be made...
The Pfizer-Trump agreement may not be enough to save the pharmaceutical industry from its current woes.
The pharmaceutical industry is facing potential challenges despite the recent deal between Pfizer and the Trump administration. In November 2020, the US government announced a $1.95 billion deal with Pfizer to provide 100 million doses of its COVID-19 vaccine....
NICE has recommended the use of Pfizer’s Lorviqua for the treatment of lung cancer.
The National Institute for Health and Care Excellence (NICE) has recently recommended Pfizer's Lorviqua (lorlatinib) as a first-line treatment for certain types of lung cancer in England. This decision follows the publication of NICE's final guidance on the therapy,...
Pfizer partner Metsera highlights promising Phase II results for its GLP-1 candidate.
Metsera Therapeutics, a biotech company set to be acquired by Pfizer, has announced positive results from two Phase II trials for its GLP-1 receptor agonist, MSE-1018. The trials evaluated the efficacy and safety of MSE-1018 in patients with type 2 diabetes and...
Former Johnson & Johnson and Pfizer executive takes the reins as new CEO of Revision Skincare.
Lisa Paley, a seasoned consumer health executive, has been appointed as the CEO of Revision Skincare, a professional-grade skincare company based in Irving. Paley brings nearly 30 years of experience leading major global brands, including Haleon, GSK, Pfizer, and...
Pfizer’s acquisition of Metsera sparks significant changes in the obesity treatment landscape.
The pharmaceutical industry is witnessing a significant shift in the obesity treatment landscape, with Pfizer's recent acquisition of Metsera, a biotech company developing an obesity therapy, being a key catalyst. This deal has major implications for the obesity race,...
Ireland’s ‘Viagra Village’ faces uncertainty amid Trump’s tariffs – Politico.eu
In the small village of Ringaskiddy, Ireland, a significant pharmaceutical plant owned by Pfizer manufactures Viagra, among other medications. The village has come to be known as "Viagra Village" due to its association with the popular erectile dysfunction medication....
Pfizer is nearing a $7.3 billion acquisition of Metsera, a company that produces anti-obesity medications, according to a report from the Financial Times.
Pfizer, a multinational pharmaceutical corporation, is reportedly nearing a $7.3 billion takeover of Metsera, a company that specializes in developing anti-obesity treatments. According to the Financial Times, the acquisition is expected to be finalized soon, pending...
ICICI Securities has identified Apollo Hospitals and Metropolis as top choices in the healthcare sector, ahead of the release of Q2 results.
ICICI Securities has released its top picks in the healthcare sector, with Apollo Hospitals and Metropolis being the favored choices. This comes ahead of the Q2 results, which are expected to be released soon. The brokerage firm has maintained a "buy" rating on Apollo...
Statement released by Fortis Mohali regarding the health status of Punjabi singer Rajvir Jawanda.
Fortis Hospital in Mohali has issued a statement regarding the condition of Punjabi singer Rajvir Jawanda, who was admitted to the hospital after being shot in the United States. According to the statement, Jawanda is currently undergoing treatment at the hospital and...
Fortis in India plans to increase the number of its obesity clinics due to a surge in demand for weight-loss treatments, according to the company’s CEO.
India's Fortis Healthcare is planning to expand its obesity clinics across the country, according to its CEO. The move comes as the demand for weight-loss therapies is on the rise. The company aims to capitalize on the growing trend of people seeking medical help to...
Fortis introduces specialized orthopaedic and sports injury outpatient department in Srinagar
Fortis Healthcare has launched a monthly Orthopaedics and Sports Injury Outpatient Department (OPD) in Srinagar, aimed at providing specialized musculoskeletal and sports medicine care to residents. The OPD will be led by Dr. Tapish Shukla, an Associate Consultant in...
Hospitals are experiencing a significant change in their revenue streams, with oncology emerging as the most lucrative department.
India's top hospital chains, including Max Healthcare, Apollo Hospitals, and Fortis Healthcare, are experiencing a significant shift in their revenue mix, with oncology emerging as the fastest-growing and most profitable specialty. Oncology, once a niche segment, is...
Punjab’s Chief Minister is exhibiting signs of improvement while being closely monitored at Fortis Hospital.
Punjab Chief Minister Bhagwant Mann was admitted to Fortis Hospital in Mohali on Friday evening due to exhaustion and a low heart rate. The 51-year-old leader has been showing improvement, with stable vital signs and gradually improving blood parameters, according to...
Punjab Chief Minister Bhagwant Mann’s condition worsens, hospitalized at Fortis Mohali
Punjab Chief Minister Bhagwant Mann has been admitted to Fortis Hospital in Mohali due to health concerns. According to reports, Mann complained of exhaustion and a low heart rate, prompting his hospitalization. The news has led to the postponement of a scheduled...
Fortis Hospital in Mohali hosts the zonal finals of ‘PSYCH-ED 2025’
Fortis Hospital, Mohali, recently hosted the zonal finals of the 8th edition of its national psychology quiz program, "PSYCH-ED, 2025". The event saw participation from over 900 schools across India, with more than 12,000 students from 190+ cities taking part in the...